Clinical Trial Update: Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue [NA]

View source ↗

Summary

A clinical trial evaluating armodafinil for patients with B-cell lymphoma and fatigue has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Washington University School of Medicine | Conditions: B-cell Lymphoma, Fatigue | NA | Status: WITHDRAWN